Business Standard

Tuesday, December 24, 2024 | 09:27 AM ISTEN Hindi

Notification Icon
userprofile IconSearch

Medicines costing less than Rs 5 per dose may be taken out of price control

If this goes through, drugmakers will have the liberty to raise the prices of these drugs by up to 10 per cent every year

Pharma, medicine, drugs, Pharmaceuticals
Premium

Sohini Das Mumbai
Medicines costing less than Rs 5 per dose may be taken out of price control as the country’s National List of Essential Medicines (NLEM) is being updated, according to sources in the industry and government. 

If this goes through, drugmakers will have the liberty to raise the prices of these drugs by up to 10 per cent every year. 

The Standing National Committee on Medicine (SNCM), which is updating the 2015 list, is likely to meet early next week (starting November 4) to have a stakeholders’ meeting.

While around 19 per cent of the Rs 1.36 trillion domestic drug market

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in